PHARMACOKINETICS OF LISINOPRIL

[1] BEERMANN B, RENAL ELIMINATION RO

[2] BEERMANN B, IN PRESS BIOPHARM DR

[3] Kwan K, 1984, PHARMACOKINETICS MOD, P147

[4] MOJAVERIAN P, 1986, J PHARM SCI, V75, P395, DOI 10.1002/jps.2600750416

[5] SJOSTROM P, IN PRESS SCAND J URO

[6] PHARMACOKINETICS AND PHARMACODYNAMICS OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (HOE 498) IN HEALTHY-SUBJECTS [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (05) : 577 - 581

[1] BEERMANN B, RENAL ELIMINATION RO

[2] BEERMANN B, IN PRESS BIOPHARM DR

[3] Kwan K, 1984, PHARMACOKINETICS MOD, P147

[4] MOJAVERIAN P, 1986, J PHARM SCI, V75, P395, DOI 10.1002/jps.2600750416

[5] SJOSTROM P, IN PRESS SCAND J URO

[6] PHARMACOKINETICS AND PHARMACODYNAMICS OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (HOE 498) IN HEALTHY-SUBJECTS [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (05) : 577 - 581